Camlipixant is an investigational new drug that has been evaluated for the treatment of chronic cough and irritable bowel syndrome. It is a P2X3 receptor antagonist.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.